Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Oncogene ; 40(11): 2065-2080, 2021 03.
Article in English | MEDLINE | ID: mdl-33627784

ABSTRACT

Pancreatic ductal adenocarcinoma (PDAC) is one of the most intractable and devastating malignant tumors. Epigenetic modifications such as DNA methylation and histone modification regulate tumor initiation and progression. However, the contribution of histone variants in PDAC is unknown. Here, we demonstrated that the histone variant H2A.Z is highly expressed in PDAC cell lines and PDAC patients and that its overexpression correlates with poor prognosis. Moreover, all three H2A.Z isoforms (H2A.Z.1, H2A.Z.2.1, and H2A.Z.2.2) are highly expressed in PDAC cell lines and PDAC patients. Knockdown of these H2A.Z isoforms in PDAC cell lines induces a senescent phenotype, cell cycle arrest in phase G2/M, increased expression of cyclin-dependent kinase inhibitor CDKN2A/p16, SA-ß-galactosidase activity and interleukin 8 production. Transcriptome analysis of H2A.Z-depleted PDAC cells showed altered gene expression in fatty acid biosynthesis pathways and those that regulate cell cycle and DNA damage repair. Importantly, depletion of H2A.Z isoforms reduces the tumor size in a mouse xenograft model in vivo and sensitizes PDAC cells to gemcitabine. Overexpression of H2A.Z.1 and H2A.Z.2.1 more than H2A.Z.2.2 partially restores the oncogenic phenotype. Therefore, our data suggest that overexpression of H2A.Z isoforms enables cells to overcome the oncoprotective barrier associated with senescence, favoring PDAC tumor grow and chemoresistance. These results make H2A.Z a potential candidate as a diagnostic biomarker and therapeutic target for PDAC.


Subject(s)
Adenocarcinoma/genetics , Carcinoma, Pancreatic Ductal/genetics , Cyclin-Dependent Kinase Inhibitor p16/genetics , beta-Galactosidase/genetics , Adenocarcinoma/drug therapy , Adenocarcinoma/pathology , Aging/genetics , Animals , Carcinoma, Pancreatic Ductal/drug therapy , Carcinoma, Pancreatic Ductal/pathology , Cell Transformation, Neoplastic/genetics , DNA Damage/drug effects , DNA Methylation/genetics , DNA Repair/drug effects , Deoxycytidine/analogs & derivatives , Deoxycytidine/pharmacology , Drug Resistance, Neoplasm/genetics , Epigenesis, Genetic/genetics , Heterografts , Histones/genetics , Humans , Mice , Gemcitabine
2.
Subcell Biochem ; 88: 407-442, 2018.
Article in English | MEDLINE | ID: mdl-29900506

ABSTRACT

Flaviviruses are positive, single-stranded, enveloped cytoplasmic sense RNA viruses that cause a variety of important diseases worldwide. Among them, Zika virus, West Nile virus, Japanese encephalitis virus, and Dengue virus have the potential to cause severe disease. Extensive studies have been performed to elucidate the structure and replication strategies of flaviviruses, and current studies are aiming to unravel the complex molecular interactions between the virus and host during the very early stages of infection. The outcomes of viral infection and rapid establishment of the antiviral state, depends on viral detection by pathogen recognition receptors and rapid initiation of signalling cascades to induce an effective innate immune response. Extracellular and intracellular pathogen recognition receptors play a crucial role in detecting flavivirus infection and inducing a robust antiviral response. One of the main hallmarks of flaviviral nonstructural proteins is their multiple strategies to antagonise the interferon system. In this chapter, we summarize the molecular characteristics of flaviviral proteins and discuss how viral proteins target different components of the interferon signalling pathway by blocking phosphorylation, enhancing degradation, and downregulating the expression of major components of the Janus kinase/signal transducer and activator of transcription pathway. We also discuss how the interactions of viral proteins with host proteins facilitate viral pathogenesis. Due to the lack of antivirals or prophylactic treatments for many flaviviral infections, it is necessary to fully elucidate how these viruses disrupt cellular processes to influence pathogenesis and disease outcomes.


Subject(s)
Flavivirus Infections/immunology , Flavivirus/immunology , Immunity, Innate , Interferons/immunology , Signal Transduction/immunology , Viral Nonstructural Proteins/immunology , Animals , Flavivirus/pathogenicity , Flavivirus Infections/pathology , Humans , Janus Kinases/immunology
3.
J Nanosci Nanotechnol ; 17(1): 846-52, 2017 01.
Article in English | MEDLINE | ID: mdl-29634187

ABSTRACT

Biodegradables Chitosan-based Nanoparticles (CS NPs) have been extensively studied as delivery system for therapeutic molecules and as efficient carriers or adjuvants in experimental vaccination. Physicochemical association between CS NPs and antigens is a key step for the biological function as carrier devices. However, for the adjuvant CS NPs property, it is not well known if coupling with vaccine antigens is required or not to potentiate the immune response. To address this issue, in this work, we evaluated the potential adjuvant effect of CS NPs by simply mixing with two different antigens such as Bovine Serum Albumin (BSA) or E protein from Dengue Virus serotype 2 (E protein DENV2). Thus the CS NPs were prepared by ionic gelation with sodium tripolyphosphate, resulting particles among 68 and 188 nm of size. Immunization of 6­8 week old female BALB/c mice, were carried out by intraperitoneal route with a simple combination of CS NPs either with BSA (CS NPs-BSA) at 10 µg or with E protein DENV2 (CS NPs-Protein E) at 5 µg. Combinations with the above antigens with CS NPs elicited robust specific primary and secondary humoral responses comparable to alum, a well-known adjuvant. BSA-specific IgG titers were detectable by day 14 after priming with the CS NPs-BSA formulation, with titers that ranged from 102 to 103 EU ml-. After a second immunization, the anti-BSA titers ranged around 104 EU ml-. In contrast, in the group of mice immunized with the protein alone, BSA-specific serum IgG titers were undetectable at day 14 and 28. For the immunizations with the CS NPs-E protein formulation, we observed also a remarkable specific-antibody production in the primary response, with titers reaching 103 EU ml-. After the booster immunization the anti-E protein DENV2 antibodies titers reached peak values around 104 EU ml-. Interestingly, for both antigens, the combination with CS NPs polarized the immune response to a Th2-like profile, which is characterized mainly by the production of the IgG1 Isotype, confirming that CS NPs can enhance and modulate the humoral immune responses against different antigens independently of physicochemical conjugation. This could represent a simplification in the use of CS NPs as adjuvants in vaccination.


Subject(s)
Adjuvants, Immunologic/chemistry , Adjuvants, Immunologic/pharmacology , Alum Compounds/chemistry , Antigens/chemistry , Chitosan/chemistry , Immunity, Humoral/drug effects , Nanoparticles/chemistry , Animals , Antigens/immunology , Mice , Mice, Inbred BALB C , Serum Albumin, Bovine/chemistry , Serum Albumin, Bovine/immunology , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/immunology
4.
Clin Exp Immunol ; 188(1): 109-126, 2017 04.
Article in English | MEDLINE | ID: mdl-27886660

ABSTRACT

Listeriolysin O (LLO) has been proposed as a potential carrier or adjuvant molecule in the vaccination field. However, the cytotoxic and pro-apoptotic effects of LLO are the major limitations for this purpose. Here, we have performed a preclinical safety evaluation and characterized a new potential adjuvant application for a non-cytolytic LLO mutant (dtLLO) to enhance and modulate the immune response against the envelope (E) protein from dengue virus. In addition, we have studied the adjuvant effects of dtLLO on human immune cells and the role of membrane cholesterol for the binding and proinflammatory property of the toxoid. Our in-vivo results in the murine model confirmed that dtLLO is a safer molecule than wild-type LLO (wtLLO), with a significantly increased survival rate for mice challenged with dtLLO compared with mice challenged with wtLLO (P < 0·001). Histopathological analysis showed non-toxic effects in key target organs such as brain, heart, liver, spleen, kidney and lung after challenge with dtLLO. In vitro, dtLLO retained the capacity of binding to plasma membrane cholesterol on the surface of murine and human immune cells. Immunization of 6-8-week-old female BALB/c mice with a combination of dtLLO mixed with E protein elicited a robust specific humoral response with isotype diversification of immunoglobulin (Ig)G antibodies (IgG1 and IgG2a). Finally, we demonstrated that cholesterol and lipid raft integrity are required to induce a proinflammatory response by human cells. Taken together, these findings support a potential use of the dtLLO mutant as a safe and effective adjuvant molecule in vaccination.


Subject(s)
Adjuvants, Immunologic , Antigens, Viral/immunology , Bacterial Toxins/immunology , Dengue Virus/immunology , Heat-Shock Proteins/immunology , Hemolysin Proteins/immunology , Immunity, Humoral , Mutant Proteins/immunology , Animals , Antibodies, Viral/immunology , Antibody Specificity/immunology , Bacterial Toxins/genetics , Cholesterol/metabolism , Cytokines/metabolism , Dendritic Cells/immunology , Dendritic Cells/metabolism , Dengue/immunology , Dengue/pathology , Dengue/prevention & control , Disease Models, Animal , Female , Heat-Shock Proteins/genetics , Hemolysin Proteins/genetics , Hemolysis/immunology , Immunization , Inflammation Mediators/metabolism , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Membrane Lipids/metabolism , Mice , Mutant Proteins/genetics , Protein Binding/immunology
5.
Immunol Invest ; 43(1): 28-40, 2014.
Article in English | MEDLINE | ID: mdl-24063571

ABSTRACT

Dengue virus (DENV) RNA replication requires 2 viral proteins, non-structural protein 3 (NS3) and NS5. NS5 consists of 2 functional domains: a methyltransferase (MTase) domain involved in RNA cap formation and located in the amino terminal region and a RNA-dependent RNA polymerase domain essential for virus replication and located in the carboxyl terminal region. To gain additional insight into the structural interactions between viral proteins and cellular factors involved in DENV RNA replication, we generated a panel of rat monoclonal antibodies (mAbs) against the NS5 MTase domain. Six rat mAbs were selected from 41 clones, of which clone 13G7 was further characterized. The specificity of this antibody for NS5 was demonstrated by western blot of DENV-infected cells, which revealed that this antibody recognizes all 4 DENV serotypes. Furthermore, Western blotting analysis suggested that this antibody recognizes a sequential epitope of the NS5 protein. Positive and specific staining with 13G7 was detected predominantly in nuclei of DENV-infected cells, similarly a pattern was observed in both in human and monkey cells. Furthermore, the NS5 staining co-localized with a Lamin A protein (Pierson index: 0.7). In summary, this monoclonal antibody could be used to identify and evaluate different cellular factors that may interact with NS5 during DENV replication.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/immunology , DNA-Directed RNA Polymerases/immunology , Dengue Virus/immunology , Viral Nonstructural Proteins/immunology , Animals , Antibody Specificity/immunology , Cell Line , Chlorocebus aethiops , DNA-Directed RNA Polymerases/genetics , DNA-Directed RNA Polymerases/isolation & purification , DNA-Directed RNA Polymerases/metabolism , Dengue Virus/classification , Dengue Virus/genetics , Humans , Lamin Type A/metabolism , Protein Binding/immunology , Protein Transport , Rats , Serotyping , Vero Cells , Viral Nonstructural Proteins/genetics , Viral Nonstructural Proteins/isolation & purification , Viral Nonstructural Proteins/metabolism
6.
Vector Borne Zoonotic Dis ; 8(1): 69-79, 2008.
Article in English | MEDLINE | ID: mdl-18279077

ABSTRACT

This study was undertaken to evaluate the feasibility of using recombinant dengue proteins to discriminate between acute dengue infections versus uninfected dengue samples. Dengue virus proteins E, NS1, NS3, and NS4B were cloned as fusion proteins and expressed in Escherichia coli. Recombinant products were tested in 100 serum samples obtained from acute dengue fever cases collected from 3 states of Mexico where dengue is endemic. Sera from 75 healthy individuals living in nonendemic areas for dengue were used as a control group. In sera from the dengue patients group, antibody responses to E protein were demonstrated in 91% of cases and NS1 protein was recognized to various extents (99%) within the first 7 days of infection. The antibody responses to NS3 and NS4B were frequently of low magnitude. Consistent negative antibody responses to all proteins were found in sera from the control group. These data suggest that the glutathione-S-transferase (GST)-dengue fusion proteins may be feasible antigens for a sensitive and specific serological assay.


Subject(s)
Antibodies, Viral/blood , Antigens, Viral/immunology , Dengue Virus/immunology , Dengue/diagnosis , Viral Nonstructural Proteins/immunology , Adolescent , Adult , Blotting, Western , Case-Control Studies , Child , Dengue/epidemiology , Enzyme-Linked Immunosorbent Assay , Escherichia coli , Feasibility Studies , Female , Humans , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Male , Mexico/epidemiology , Middle Aged , Recombinant Proteins/immunology , Sensitivity and Specificity , Serologic Tests
7.
Vaccine ; 25(27): 5071-85, 2007 Jun 28.
Article in English | MEDLINE | ID: mdl-17543427

ABSTRACT

Attenuated Salmonella strains are used widely as live carriers of antigens because they elicit both mucosal and systemic immunity against passenger antigens. However, they generally evoke poor cytotoxic T cell (CTL) responses because Salmonella resides within vacuolar compartments and the passenger antigens must travel to the cytosol and be processed through the MHC class I-dependent pathway to simulate CTLs. To address this problem, we designed a fusion protein to destabilize the phagosome membrane and allow a dengue epitope to reach the cytosol. The fusion protein was displayed on the bacterial surface of Salmonella enterica serovar Typhimurium SL3261 through the beta domain of the autotransporter MisL. The passenger alpha domain contained, from the N-terminus, a fusogenic sequence, the NS3 protein 298-306-amino acid CTL epitope from the dengue virus type 2, a molecular tag, and a recognition site for the protease OmpT to release it to the milieu. Display of the fusion protein on the bacterial surface was demonstrated by IFA and flow cytometry using antibodies against the molecular tag. Cleavage of the fusogenic protein-dengue peptide was demonstrated by flow cytometry using OmpT+ Escherichia coli strains. The recombinant Salmonella strains displaying the fusogenic-dengue peptide were able to lyse erythrocytes, induced specific proliferative responses, and elicited CTL responses. These results suggest that the recombinant fusion proteins containing fusogenic sequences provide a promising system to induce CTLs by live vector vaccines.


Subject(s)
Dengue Vaccines/biosynthesis , Dengue Vaccines/immunology , Salmonella enterica/metabolism , T-Lymphocytes, Cytotoxic/immunology , Animals , Base Sequence , Cell Line, Tumor , Cell Proliferation , Chromium/metabolism , Dengue/immunology , Dengue Vaccines/genetics , Dengue Virus/immunology , Epitopes/immunology , Erythrocytes/drug effects , Escherichia coli/metabolism , Flow Cytometry , Fluorescent Antibody Technique , Hemolysis/drug effects , In Vitro Techniques , Mice , Mice, Inbred BALB C , Oligonucleotides , Plasmids , Salmonella enterica/genetics , Sheep , Vaccines, Subunit/biosynthesis , Vaccines, Subunit/genetics , Vaccines, Subunit/immunology , Viral Fusion Proteins/biosynthesis , Viral Fusion Proteins/immunology
8.
Hybridoma (Larchmt) ; 24(3): 160-4, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15943564

ABSTRACT

Dengue is considered a reemerging disease of worldwide distribution. The Dengue virus non-structural protein 3 (NS3) is known to possess ATPase, helicase, and protease activities that are a constitutive part of the replication complex of Dengue virus. In this report, we discuss the cloning, expressing, and purifying of the Dengue-2 NS3 protein, to immunize mice and then generate monoclonal antibodies (MAbs). Our results show the production of MAbs specific to NS3 protein of Dengue-2 virus, which by immunofluorescence recognize the native protein in experimentally infected endothelial cells (HMEC). Likewise, C6/36-infected lisates were used in Western blots, and observed the specific characteristic band that defines the NS3 protein. We conclude that these antibodies may be a useful tool, not only to study the replicative process of Dengue virus, but also to generate specific diagnostic tools for Dengue infection.


Subject(s)
Adenosine Triphosphatases/immunology , Antibodies, Monoclonal/immunology , Antibody Specificity/immunology , Dengue Virus/immunology , Immunization , Serine Endopeptidases/immunology , Animals , Antibodies, Monoclonal/biosynthesis , Blotting, Western , Cloning, Molecular , Dengue Virus/chemistry , Dengue Virus/isolation & purification , Electrophoresis, Polyacrylamide Gel , Endothelial Cells/virology , Enzyme-Linked Immunosorbent Assay , Escherichia coli/genetics , Fluorescent Antibody Technique, Indirect , Glutathione Transferase/metabolism , Humans , Mice , Mice, Inbred BALB C , Microscopy, Fluorescence , Polymerase Chain Reaction , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/metabolism , Serine Endopeptidases/genetics , Serine Endopeptidases/isolation & purification , Serine Endopeptidases/metabolism
11.
Parasite Immunol ; 15(3): 143-51, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8316408

ABSTRACT

The transfer of spleen cells from (BALB/c x C57Bl/6) F1 mice recovered from a Plasmodium chabaudi chabaudi AS infection into irradiated syngeneic recipients conferred protection. Neither elimination of Thy-1+ cells nor in vitro irradiation of immune cells before transfer affected protection while both anti-Thy-1 treatment and irradiation abolished the appearance of anti-P. c. chabaudi antibodies in the recipients. Superinfection of immune spleen cell donors did not improve their capability to transfer protection which was also unaffected by anti-Thy-1 treatment. The serum of mice after one infection was only marginally protective when transferred into irradiated recipients and a second infection improved the protective activity of serum which was not further improved by six infections. The co-transfer of immune serum and immune cells did not result in any synergistic effect. On the other hand, when P. c. chabaudi AS (BALB/c x C57Bl/6) F1 infected mice were challenged with a high dose of Plasmodium yoelii 17XL at crisis, the mice were unable to control the heterologous parasite. When mice were challenged with P. yoelii 17XL several weeks after infection with P. c. chabaudi AS, a good degree of cross-protection was observed.


Subject(s)
Immunotherapy, Adoptive , Isoantibodies/immunology , Malaria/prevention & control , Plasmodium chabaudi/immunology , Spleen/immunology , Animals , Antibodies, Monoclonal/immunology , Antibodies, Protozoan/biosynthesis , Female , Immune Sera/immunology , Malaria/blood , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Plasmodium yoelii/immunology , Species Specificity , Spleen/cytology , Spleen/radiation effects , T-Lymphocytes/immunology , T-Lymphocytes/radiation effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...